Selve tilbageholdelsestiden for produktet skal imidlertid baseres på restkoncentrationerne på injektionsstedet.
Further reassurance as to the adequacy of this withdrawal period is provided by the fact that at 46 days residues were below the LOQ in all injection site samples.